Methods of administering 3,4-diaminopyridine
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 6, 2020
Grant Date -
Sep 11, 2014
app pub date -
Jun 29, 2012
filing date -
Jun 30, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully